HMOX1 and pemphigus foliaceus: Current evidence indicates that empagliflozin demonstrates a promising ability to protect against bleomycin-induced PF in rats by inhibiting ferroptosis via modulating the Sesn2/AMPK/Nrf2/HO-1 signaling pathway.